- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07623772
Confident Moves Intervention Efficacy Trial: Obesity Care Settings
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Seungmin Lee, PhD
- Telefonnummer: 515-294-8257
- E-mail: seunglee@iastate.edu
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Age 18-64 years
- Body Mass Index (BMI) ≥ 25 kg/m²
- Access to a technological device (e.g., computer, smartphone) capable of supporting the online intervention
- Not currently enrolled in another physical activity (PA) intervention (except standard obesity care programs at participating centers)
- Willingness to wear a wrist worn accelerometer for two separate 7 day monitoring periods
- Willingness to respond to study related communications (e.g., email, text, phone call)
Exclusion Criteria:
- Failure to meet one or more of the inclusion criteria
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Standard Care Group
Participants assigned to the standard care group will receive only the obesity centers' standard obesity care program during the data collection period.
They will be provided with login credentials to access the CM website for data collection at wave 1 (W1), wave 2 (W2), and wave 3 (W3).
|
|
|
Eksperimentel: CM Group
Participants assigned to the Confident Moves (CM) group also will receive the obesity centers' program and will be provided with 4 weeks of continuous (24-hour) access to the CM intervention during the data collection period.
Access to the CM intervention will become available between W1 and W2, and those in this group will be notified via email.
They will be encouraged to actively engage with the intervention, including completing at least 26 intervention challenges.
They will be provided with login credentials to access the CM website for both the CM intervention and data collection at W1, W2, and W3.
|
Confident Moves (CM) is a web-based physical activity (PA) intervention designed to integrate with obesity care and support daily PA in adults with obesity.
A 2025 feasibility trial supported the development of a future randomized controlled trial and identified areas for refinement.
Grounded in social cognitive theory, CM targets self-efficacy through structured learning activities such as games, videos, lectures, and self-reflection, incorporating behavior change techniques like goal setting and action planning.
The online program includes seven components addressing multiple PA domains and mindfulness, delivered over 4 weeks with flexible access.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
ActiGraph wGT3X-BT
Tidsramme: At W1 (Week 1-4) and W3 (Week 13-16)
|
Device-measured physical activity (PA) will be assessed at W1 and W3 using the ActiGraph wGT3X-BT (Pensacola, FL, USA), a tri-axial research-grade accelerometer.
Devices will collect data at 30 Hz and be reintegrated into 60-s epochs.
Non-wear will be defined as ≥90 consecutive minutes of zero counts, allowing ≤2 min of nonzero counts if surrounded by ≥30 min of zeros.
Data will be considered valid if participants have ≥3 days with ≥10 h/day of wear, no device malfunction, and consistency with logs.
Moderate-to-vigorous PA (MVPA) will be defined as ≥3,941 counts/min using wrist-specific vector magnitude cut-points validated in free-living adults.
|
At W1 (Week 1-4) and W3 (Week 13-16)
|
|
Whole Person Health Index (WPHI) scale
Tidsramme: At W1 (Week 1-4) and W3 (Week 13-16)
|
The Whole Person Health Index (WPHI) will be measured at W1 and W3 using a 9-item self-reported scale developed by the National Center for Complementary and Integrative Health, in collaboration with the Centers for Disease Control and Prevention.
The WPHI assesses overall health across physical, psychological, and social domains, reflecting a whole person health framework beyond disease-specific outcomes.
Items assess general health, quality of life, social/family connections, diet, physical activity, stress management, sleep, meaning/purpose, and ability to manage health, rated on a 5-point Likert scale (1=poor to 5=excellent).
The WPHI is validated and used in observational and clinical studies, including the 2025 National Health Interview Survey.
Total scores range from 9 to 45, with higher scores indicating better health outcomes.
|
At W1 (Week 1-4) and W3 (Week 13-16)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Physical Activity Self-Efficacy (PASE) scale
Tidsramme: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]
|
Physical Activity Self-Efficacy (PASE) will be assessed at W1 and W2 using a 36-item self-reported scale measuring confidence in achieving recommended weekly physical activity (PA).
PASE evaluates self-efficacy across four domains: occupational, transport, domestic, and leisure PA.
Occupational and leisure domains include moderate- and vigorous-intensity activities, whereas transport and domestic domains include moderate-intensity activities only.
Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence), consistent with standard self-efficacy measures.
Total scores range from 0 to 144, with higher scores indicating greater PA self-efficacy.
|
[Time Frame: At W1 (Week 1-4) and W2 (Week 9)]
|
|
Self-Efficacy to Regulate Physical Activity (SERPA) scale
Tidsramme: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]
|
Self-efficacy to regulate physical activity (SERPA) will be measured at W1 and W2 using a 13-item version of the SERPA scale. This scale will assess participants' confidence in their ability to overcome barriers to sustaining weekly PA. Previous measurement studies of the SERPA scale indicate a two-factor structure reflecting different types of barriers to PA. Items are rated on a five-point self-efficacy scale (0 = no confidence to 4 = complete confidence). Total scores range from 0 to 52, with higher scores indicating better outcomes. |
[Time Frame: At W1 (Week 1-4) and W2 (Week 9)]
|
|
Self-Efficacy for Whole Person Health (SE-WPH) scale
Tidsramme: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]
|
Self-Efficacy for Whole Person Health (SE-WPH) will be measured at W1 and W2 using a newly developed 9-item self-reported scale.
The SE-WPH assesses confidence in engaging in and sustaining behaviors that support whole person health across physical, psychological, and social domains, aligned with the Whole Person Health Index (WPHI).
Items reflect key areas including overall health and quality of life, social connections, health behaviors (diet, physical activity, sleep, stress), and health self-management.
Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence).
Psychometric evaluation (reliability and validity) will be conducted prior to hypothesis testing.
Total scores range from 0 to 36, with higher scores indicating greater self-efficacy.
|
[Time Frame: At W1 (Week 1-4) and W2 (Week 9)]
|
|
Self-Efficacy to Engage (SE-E) scale
Tidsramme: [Time Frame: At W2 (Week 9)]
|
Self-Efficacy to Engage (SE-E) will be measured at W2 among participants in the CM group upon access to the intervention, using a previously developed 7-item self-reported scale.
The SE-E assesses confidence in engaging with the online intervention and is conceptually aligned with subjective engagement.
An example item is: "How confident are you in your current ability to pay close attention when engaging with this online intervention?"
Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence).
Although previously developed, the scale was only used in a feasibility trial; thus, reliability and validity will be evaluated prior to hypothesis testing.
Total scores range from 0 to 28, with higher scores indicating greater engagement self-efficacy.
|
[Time Frame: At W2 (Week 9)]
|
|
Physical Activity Outcome Expectations (PAOE) scale
Tidsramme: [Time Frame: At W1 (Week 1-4), W2 (Week 9), and W3 (Week 13-16)]
|
Physical Activity Outcome Expectations (PAOE) will be assessed at W1, W2, and W3 using a modified 13-item self-reported scale capturing beliefs about expected outcomes of physical activity (PA).
The scale was adapted from the Multidimensional Outcome Expectations for Exercise scale, grounded in social cognitive theory and encompassing physical, social, and self-evaluative domains.
Modifications were informed by responses from 30 adults with obesity in a 2025 feasibility trial, using inductive analyses and independent item review to enhance relevance to obesity-specific PA contexts.
An example item is: "Physical activity will improve my stamina for daily activities."
Items are rated on a 5-point scale (1 = strongly disagree to 5 = strongly agree).
Psychometric evaluation will be conducted prior to hypothesis testing.
Total scores range from 13 to 65, with higher scores indicating more positive outcome expectations.
|
[Time Frame: At W1 (Week 1-4), W2 (Week 9), and W3 (Week 13-16)]
|
|
Subjective Engagement (SE) scale
Tidsramme: [Time Frame: W2 (Week 9)]
|
Subjective engagement (SE) will be assessed among participants assigned to the CM group after intervention access is provided, using a newly developed subjective engagement scale. This 7-item measure is designed to assess participants' subjective engagement with the web-based intervention, consistent with conceptualizations of engagement in the online behavioral intervention literature. An example item is: "I paid close attention when engaging with this online intervention." Responses will be recorded using a five-point Likert scale (i.e., 0 = not at all to 4 = completely). Because the engagement scale is newly developed, evidence regarding the validity and reliability of scores derived from this measure will be evaluated using data collected at W1. Total scores range from 0 to 28, with higher scores indicating better outcomes. |
[Time Frame: W2 (Week 9)]
|
|
Support from Obesity Care Centers for Physical Activity (SOCC) scale
Tidsramme: [Time Frame: At W1 (Week 1-4)]
|
Support from Obesity Care Centers (SOCC) will be assessed at W1 using a 7-item self-reported scale informed by the 2025 CM feasibility trial.
The SOCC assesses experiences with and perceptions of physical activity (PA)-related support received outside the CM intervention.
It includes a screening item on receipt of PA support, followed by conditional items assessing type of support and satisfaction.
Participants reporting support describe it in open-ended form and rate satisfaction on a 5-point scale (1 = very dissatisfied to 5 = very satisfied).
Additional items assess referrals to PA resources and perceived preferences, needs, and barriers.
Data will be used descriptively to contextualize PA support and inform intervention refinement.
Total scores range from 7 to 35, with higher scores indicating greater perceived support.
|
[Time Frame: At W1 (Week 1-4)]
|
|
International Physical Activity Questionnaire-Short Form (IPAQ-SF) scale
Tidsramme: [Time Frame: At W1 (Week 1-4) and W3 (Week 13-16)]
|
Self-reported PA will be measured at W1, W2, and W3 with the short form of International Physical Activity Questionnaire (IPAQ).
This questionnaire assesses the frequency and duration of walking, moderate-, and vigorous-intensity PA over the past 7 days.
Average minutes per day of moderate-to-vigorous physical activity (MVPA) will be calculated based on the IPAQ guidelines.
|
[Time Frame: At W1 (Week 1-4) and W3 (Week 13-16)]
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 26-187
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Confident Moves (CM) Intervention
-
University GhentResearch Foundation Flanders; Agentschap Zorg en Gezondheid, Belgium; Vlaams...AfsluttetDepressive symptomer | Trivsel | Livsstil, sund | ModstandsdygtighedBelgien
-
VA Office of Research and DevelopmentAfsluttet
-
Karen Derefinko, PhDUniversity of New Mexico; University of MemphisAfsluttetOpioidafhængighed | Behandlingsoverholdelse | OpioidbrugsforstyrrelseForenede Stater
-
Universita di VeronaAfsluttet
-
Oregon Health and Science UniversityOregon Health Authority; Clatsop Behavioral Healthcare; Clatsop County CorrectionsIkke rekrutterer endnuOpioidbrugsforstyrrelseForenede Stater